Page 18 - Sure Technologies News Today

/PRNewswire/ -- The "OTC/DTC Infectious Disease Diagnostics Market Report 2021" report has been added to ResearchAndMarkets.coms offering. The report has...

Recent Developments - Importance and How to Use This Section Importance of These Developments FemtoDx Launches Rapid At-Home Test Development for COVID-19 FDA approves first at-home coronavirus test Free Home HIV Tests Detect More Infections Biohacking trend supports self testing. PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distri...

Local players for the week of May 30

DNA & RNA Banking Services Market: Comprehensive Study Explore Huge Growth in Future | EasyDNA, Thermo Fisher Scientific, Inc, OraSure Technologies, Inc.,

Published: May 17, 2021 BETHLEHEM, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications effective today. Prior to joining OraSure, Mr. Gleason served as the Senior Vice President of Investor Relations and Corporate Str...

Share this article Share this article ResearchAndMarkets.coms offering. This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present - March 31, 2021. For the purp...

Intellia Therapeutics, Inc. (NASDAQ: NTLA) (before the market open) Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (before the market open) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (before the market open) Insmed Incorporated (NASDAQ: INSM) (before the market open) Fulcrum Therapeutics, Inc. (NASDAQ: FULC) (before the market open) Endo International plc (NASDAQ: ENDP) (before the market open) Bio-Techne Corporation (NASDAQ: TECH) (before the market open) Harvard Bioscience, Inc. (NASDAQ: H...

Points of Interest: Lufax Holding (NYSE:LU) was the largest, in terms of market cap, to set a new 52-week low. Powerbridge Technologies (NASDAQ:PBTS) is the smallest company on a market cap basis to set a new 52-week low. Relay Therapeutics (NASDAQ:RLAY) was the biggest loser, trading down 6.32% to reach its 52-week low. Here are all the stocks that set new 52-week lows as of 10 a.m. ET on Friday: Lufax Holding (NYSE:LU) shares fell to $12.25 on Friday, setting a new 52-week low with a shift of...

Published: Apr 29, 2021 The infectious disease in-vitro diagnostics market is prognosticated to observe promising growth across the assessment period of 2020-2030 on the back of the rising prevalence of infectious diseases around the world. The increasing incidences of infectious diseases and the growing need to tackle them at an early stage have led to tremendous advancements in terms of diagnostics. Infectious disease in-vitro diagnostics is one of them. Thus, this aspect will bring good ...

4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development1 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit Stanford Developing Low-Cost...